Many in the chemical process industries (CPI) view generative artificial intelligence (genAI) as a powerful augmentation ...

As generative artificial intelligence is incorporated into medical device technologies, there are undoubtedly going to be questions. What are the safety measures that should be enacted? Are there any ...

Generative AI stunned the world a couple of years back by producing text, pictures, code, and analysis at previously unheard-of speeds and scales. But in 2026, something more potent and significant is ...

Finance chiefs face genAI hype pressure as efforts to combine its user-friendly benefits with machine learning are still evolving, Matthias Steinberg says.

Massimiliano Moruzzi, CEO of Xaba, argues that industrial automation is highly inefficient because it relies on outdated controllers, rigid programming and exhaustive manual intervention. Programming ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry challenges like the "patent cliff" and high clinical failure rates. AI-driven ...

ElastixAI solves the systemic inefficiencies of GenAI inference through innovative software-ML-hardware co-design, delivering the next generation of scalable, sustainable AI. The founding team brings ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...